Eli Lilly plans to globally launch its diabetes and weight-loss drug, Mounjaro, in countries including China, India, Brazil, ...

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli ...

The physical letters claim to come from the BianLian ransomware group. But the FBI says no one has been hacked, and it's just ...

The Indiana State Police has finished an investigation into Sharon McBride and St. Joseph County’s DuComb Center, and now a ...

The new investments aren't solely dedicated to Eli Lilly's current and future obesity and diabetes treatments. The company is charting its future beyond Zepbound and Mounjaro, with hopes to ...

Drugmaker Eli Lilly ... agenda. Lilly has been working to increase manufacturing capacity to meet the massive demand for its blockbuster diabetes and weight-loss drugs Zepbound and Mounjaro.

Much of Eli Lilly’s recent investments have been focused on meeting the ballooning demand for its blockbuster diabetes and weight loss medications Mounjaro and Zepbound, part of a new class of ...

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States ...